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Abstract
Background: We evaluated the optimal radiotherapy (RT) plan for synchronous bilateral breast cancer (SBBC),
especially treatment plans including the regional lymph node (LN) area.
Methods: This study was conducted using 15 patients with SBBC (5 with small breasts, 5 with large breasts, and 5
who underwent a left total mastectomy). The clinical target volume (CTV) was defined as the volume enveloping
the bilateral whole breasts/chest wall and left regional LN area. We established the following plans: 1) volumetric-
modulated arc therapy (VMAT)-the only plan using two pairs of partial arcs for the whole target volume, 2) VMAT
using one partial arc for the left CTV followed by a 3D tangential technique for the right breast (primary hybrid
plan), and 3) VMAT for the left CTV followed by a tangential technique using an automatically calculated
prescription dose for the right breast, considering the background dose from the left breast VMAT plan (modified
hybrid plan). The Tukey test and one-way analysis of variance were used to compare the target coverage and doses
to organs at risk (OARs) of the three techniques.
Results: For target coverage, the VMAT-only and modified hybrid plans showed comparable target coverage in
terms of Dmean (50.33 Gy vs. 50.53 Gy, p = 0.106). The primary hybrid plan showed the largest distribution of the
high-dose volume, with V105% of 25.69% and V110% of 6.37% for the planning target volume (PTV) (p < 0.001). For
OARs including the lungs, heart, and left anterior descending artery, the percentages of volume at various doses
(V5Gy, V10Gy, V20Gy, V30Gy) and Dmean were significantly lower in both the primary and modified hybrid plans
compared to those of the VMAT-only plan. These results were consistent in subgroup analyses of breast size and
morphological variation.
Conclusions: The modified hybrid plan, using an automatically calculated prescription dose for the right breast and
taking into consideration the background dose from the left breast VMAT plan, showed comparable target
coverage to that of the VMAT-only plan, and was superior for saving OARs. However, considering that VMAT can be
adjusted according to the physician’s intention, further evaluation is needed for developing a better plan.
Keywords: Radiotherapy dosage, Breast Cancer, Volumetric-modulated arc therapy, Organs at risk
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: ikjae412@yuhs.ac
Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei
University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273,
Korea
Cho et al. Radiation Oncology           (2019) 14:56 
https://doi.org/10.1186/s13014-019-1257-5
Background
Breast cancer is the most common cancer in women,
and 1–2% of these patients are diagnosed with syn-
chronous bilateral breast cancer (SBBC) [1]. While the
incidence of SBBC is low, it presents significantly poorer
overall survival than that of unilateral breast cancer [2,
3]. There is no standard guideline for treating SBBC,
and owing to an increasing demand for
breast-conserving treatment in many cases, synchronous
bilateral breast irradiation is commonly required.
Radiotherapy (RT) for unilateral breast cancer has
used a tangential field with two-dimensional (2D) or
three-dimensional conformal radiotherapy (3D-CRT).
However, when the traditional field is applied to SBBC,
overlapping of the RT fields could be inevitable, thereby
compromising the target coverage. There is also a prob-
lem with the daily set-up of the patients, especially in
the case of RT including regional node irradiation (RNI).
Multiple isocenters are used in this method, so setting
up the patient’s posture may often be inaccurate. More-
over, a larger treatment volume is required for SBBC, so
the radiation dose to organs at risk (OARs), like the lung
and heart, is considerable.
For treating such a complex target volume, recent
trends have shown that intensity-modulated radiation
therapy (IMRT) using helical tomotherapy or
volumetric-modulated arc therapy (VMAT) are applied.
When IMRT is used for SBBC, problems associated with
the isocenter and junction can be solved. Because the ir-
radiation beam in IMRT emits in many directions, a
large volume of the lung and heart may be irradiated un-
necessarily during bilateral breast treatment. Therefore,
physicians have tried to reduce the dose to OARs by
using hybrid-VMAT, limiting the beam direction, or
using a static angle only in tomotherapy [4–6].
However, there is still no standard for the best plan,
and in most previous studies, only RT for bilateral
breasts without RNI was considered. In addition, the op-
timal RT plan considering the morphologic variation of
patients (e.g. large/small breasts or a funnel-like chest)
has not been reported. In this study, we evaluated the
optimal RT plan for SBBC, especially treatment plans in-
cluding RNI, and analyzed the strategies considering the
patients’ morphologic variations.
Methods
Patients selection and planning objectives
In order to consider various breast sizes and types of
breast surgery, we included 10 patients who received bi-
lateral partial mastectomy (5 with small breasts and 5
with large breasts) and 5 patients who received a right
breast partial mastectomy and a left breast total mastec-
tomy. A small breast was defined as one where the
depth from the nipple to the chest wall was < 3 cm in an
axial computed tomography (CT) image, whereas a large
breast was defined as one where the depth was > 3 cm
(Additional file 1: Figure S1). The patients were immobi-
lized in a supine position on a breast board with both
arms raised, and planning CT was conducted.
The clinical target volume (CTV) for the breast, chest
wall, and lymph node (LN) were contoured with refer-
ence to the Radiation Therapy Oncology Group con-
touring atlas [7]. To closely examine the irradiation dose
to the heart, treatment of LN area was set to the left
side. Thus, the CTV was defined as the volume that
enveloped the bilateral whole breasts (or the right breast
and left chest wall) and the left regional LN area, includ-
ing the internal mammary, axillary level I, II, III, and
supraclavicular LNs. The planning target volumes
(PTVs) were obtained by 5 mm expansion in all direc-
tions from the CTVs and were also restricted to have a
skin gap (trim) of 3 mm from the surface in the case of
breast CTV. However, for patients who received a total
mastectomy, we included the skin in the CTV without a
gap. The whole lung, heart, and left anterior descending
artery (LAD) were considered OARs.
The prescribed dose was 50.4 Gy at 1.8 Gy per fraction
to the PTVs. Radiation boost to the tumor bed was not
included in this study. The primary aim in RT planning
was to deliver 95% of the prescribed dose in 95% of the
PTV. For planning approval, PTV D95% ≥ 47.8 Gy, a
near-maximum dose (D2%) ≤ 55.4 Gy to the PTV, and a
minimum dose to 95% of both PTVs that is not lower
than 95% of their respective prescribed doses were re-
quired. As no distinct treatment protocol has been sug-
gested for bilateral breast cancer, the OAR dose
constraints guideline was established based on a study of
several patients with unilateral breast cancer [8] and pre-
vious SBBC research [9]. The irradiation dose to the
OARs was restricted as follows: the planning objectives
were a mean lung dose of 15 Gy with V20Gy < 30% (no
more than 30% of the OAR volume receiving 20 Gy) for
the lungs and V25Gy < 20% for the heart. For the LAD,
an objective of 25 Gy for the maximum dose (Dmax) was
retained. A bolus was not used for any chest wall
planning.
Planning techniques
The RT plans were generated using RayStation software
version 5.2 (RaySearch Laboratories, Sweden) and all
plans were made for treatment on a Versa HD radiother-
apy system (Elekta). The energy of 6 MV photon was
used in all VMAT and 3D CRT plans.
Using only VMAT for the whole PTV (VMAT-only plan)
For the VMAT-only plan, a single isocenter was used for
the whole PTV. The plans used two pairs of partial arcs
with a total length of 240° per arc (clockwise and
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counterclockwise), which consisted of a rotating beam
on each breast. The starting gantry angle was 240° and
the stop gantry angle was 120° for all patients. A fixed
collimator angle is generally recommended to avoid an
excessive inter-leaf leakage dose to the patient during
VMAT. The impact is different depending on certain
factors such as MLC type. With reference to previous
papers on VMAT plans for the breast, the collimator
and couch angles in this study were set at zero, and only
a coplanar beam was used [4, 10, 11]. No monitor unit
constraint was used in order to allow maximum OAR
sparing.
VMAT planning for the left breast followed by
conventional 3D-tangential technique for the right breast
(primary hybrid plan)
To cover the left PTV, one partial arc was used with a
total length of 195°, a starting gantry angle between 300°
and 305°, and a stop angle between 140° and 145°. After
completing the VMAT plan for the left PTV, the right
breast PTV was planned with a conventional tangential
field, without considering the background dose of the
previous VMAT plan. A total dose of 50.4 Gy with 28
fractions was prescribed at the prescription point of the
right breast PTV.
VMAT planning for the left breast followed by
conventional tangential technique for the right breast,
considering the background dose of previous VMAT
planning (modified hybrid plan)
The VMAT plans for the left PTV in this method were
the same as those of the primary hybrid plan. However,
owing to the out-of-field dose distribution of the left
VMAT plan in the right breast (Additional file 2: Figure
S2), following the 3D plan may result in a high dose area
if we use the prescribed dose of 50.4 Gy as is. Thus, we
set the dose distribution of the previous left VMAT plan
as a background dose when setting the new beam for
the right breast. The multiple beam set planning in
RayStation enables the optimization of the summed dose
distribution for both VMAT and the 3D plan simultan-
eously. Objective functions can be assigned to each
beam set dose, or to their sum. In this plan, the RaySta-
tion system calculated the background dose distributions
in the right PTV, and automatically adjusted the dose of
the prescription point to a final dose of 50.4 Gy.
Analysis of plans
The plans were evaluated by dose-volume histogram
(DVH) analysis. For PTV, the mean doses and values of
V105% and V110% (the percentage of the PTV receiving at
least 105 and 110% of the prescribed dose, respectively),
Dmax, and Dmean (mean dose) were reported. The D98%
and D2% (minimum dose to 98 and 2% of the PTV) were
also reported. The conformity index (CI) was measured
by BV95% (defined below), and the dose homogeneity
index (HI) was measured by D5%/D95% [12]. CI and HI
were calculated using the definitions below, and the
closer the CI and HI values are to 1, the better the con-
formal coverage:
CI ¼ BV95%=PTV volume
(BV95% = body volume of the isodose of 95% of the
prescribed dose)
HI ¼ D5%=D95%
(D5% =minimum dose to 5% of the PTV, D95% =mini-
mum dose to 95% of the PTV)
To evaluate the irradiated dose to OARs, the analysis
included the mean dose and VXGy (OAR volume receiv-
ing X Gy), depending upon the organ. For the lung, inci-
dence of radiation pneumonitis (RP) was < 20% when
the mean lung dose was less than approximately 20 Gy.
With regard to Vdose threshold models, the risk of RP
was < 20% for V20 < 30–35% or V5 < 60% with conven-
tional fractionation [13–15]. The V30Gy, V25Gy, and Dmean
for the heart were compared; V20Gy, V10Gy, Dmax, and
Dmean for LAD were also compared. The Tukey test and
one-way ANOVA were used to compare the PTV and
OAR values of the three techniques. Statistical analyses
were performed using SPSS software version 23 (IBM
Corp, Armonk, NY). Differences were reported to be
statistically significant at p < 0.05.
Results
Target dose distribution
The median pathologic tumor size of the 15 patients was
1.7 cm (range, 0.4–3.8 cm) for the left breast and 0.8 cm
(range, 0.1–2.8 cm) for the right breast. Mean volume of
the whole PTV was 988.6 ± 327.6 ml; the range of PTV
volume was from 410.0 ml to 1765.5 ml. In the modified
hybrid plan, the mean prescribed dose to the right PTV
was 48.09 Gy (± 0.93 Gy) at the prescription point. The
characteristics of the 15 patients in this study are pre-
sented in Additional file 3: Table S1.
Table 1 shows the Dn% (dose (Gy) to n% of the PTV),
Vm% (percentage of the PTV receiving ≥m% of pre-
scribed dose), Dmean, and Dmax. The primary hybrid plan
showed the largest distribution of high-dose volume
with a V105% of 25.69% and V110% of 6.37% in the PTV
(p < 0.001). This plan also showed the highest Dmax
(59.21 ± 1.29 Gy), followed by the modified hybrid (56.2
± 1.31 Gy) and VMAT-only plans (54 ± 1.14 Gy). The
modified hybrid plan showed higher V105% than the
VMAT-only plan, but V110% did not differ between the
two plans. Figure 1 shows the isodose distribution of
one patient treated with various radiotherapy plans.
Cho et al. Radiation Oncology           (2019) 14:56 Page 3 of 8
The VMAT-only plan and modified hybrid plan
showed comparable target coverage according to Dmean
with mean values of 50.33 Gy and 50.53 Gy, respectively
(p = 0.106), whereas the primary hybrid plan showed
higher Dmean. Although D98% and D2% were not signifi-
cantly different between the 3 RT plans, D98% for the
VMAT-only plan was the lowest, with a large standard
deviation, indicating that the D98% of the VMAT-only
plan is distributed widely around the mean value. There
was also no significant difference in CI. However, the
VMAT-only plan showed the best HI value (1.07 ± 0.02),
followed by the modified hybrid (1.11 ± 0.03) and pri-
mary hybrid plans (1.18 ± 0.03) (p < 0.001).
Among the 10 patients who received bilateral partial
mastectomy, 5 had small breasts and the other 5 had
large breasts. In the subgroup analysis for patients with
small breasts, the VMAT-only and modified hybrid plans
showed equivalent target coverage in terms of Dmean
(50.3 Gy vs 50.6 Gy, p = 0.057), whereas the primary hy-
brid plan showed a high Dmean value (51.6 Gy, p < 0.001)
Table 1 The comparison of planning target volume (PTV) coverage for VMAT only, primary hybrid, and modified hybrid plan using
dosimetric parameters
Treatment plans
VMAT only1) Primary hybrid plan2) Modified hybrid plan3) p value pa
PTV parameters Mean (SD) Mean (SD) Mean (SD) 1) vs 2) 1) vs 3) 2) vs 3)
V95% (%) 96.7 (1.16) 97.1 (1.58) 95.3 (2.07) 0.026 0.821 0.079 0.02
V105% (%) 0.3 (0.62) 26.7 (6.81) 6.4 (2.32) < 0.001 < 0.001 0.001 < 0.001
V110% (%) 0.0 (0) 6.2 (3.18) 0.4 (0.73) < 0.001 < 0.001 0.87 < 0.001
D98% (Gy) 44.6 (7.91) 47.5 (0.6) 47.7 (0.8) 0.145 0.225 0.181 0.992
D2% (Gy) 54.0 (2.2) 54.4 (2.3) 54.0 (1.8) 0.81 0.824 0.998 0.859
Dmean 50.3 (0.06) 51.6 (0.36) 50.5 (0.27) < 0.001 < 0.001 0.106 < 0.001
Dmax 54.0 (1.14) 59.2 (1.29) 56.2 (1.31) < 0.001 < 0.001 < 0.001 < 0.001
CI 1.50 (0.18) 1.46 (0.15) 1.49 (0.18) 0.862 0.856 0.986 0.927
HI 1.07 (0.02) 1.18 (0.03) 1.11 (0.03) < 0.001 < 0.001 < 0.001 < 0.001
pa: Post-Hoc Analysis Using Tukey’s HSD test
Fig. 1 Isodose distribution of individual patients treated with various radiotherapy plans. The VMAT-only (a), primary hybrid (b), and modified
hybrid plans (c) are shown. High dose areas (107% of the prescribed dose) are represented with yellow color
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(Additional file 3: Table S2). HI (1.1 ± 0.01 p < 0.001) was
best in the VMAT-only plan, while D98%, D2%, and CI
showed no significant differences between the three
plans.
For patients with large breasts, the VMAT-only and
modified hybrid plans also showed comparable target
volume coverage regarding Dmean. Moreover, HI was not
significantly different between the VMAT-only plan and
modified hybrid plan. Additional analysis for those who
received a left breast total mastectomy showed results
consistent with those of the patients with large breasts.
All three subgroup analyses by breast shape (small, large,
and total mastectomy) revealed that Dmax, V105%, and
V110% were significantly higher in the primary hybrid
plan than the other two plans (Additional file 3: Table
S3).
OAR dose distribution
Regarding the whole lung, the average Dmean of all cases
was 12.6 ± 1.6 Gy, while V5Gy, V10Gy, and V20Gy were
60.5 ± 9.1%, 36.1 ± 7%, and 21.9 ± 4.6%, respectively.
Table 2 shows the statistical comparison of the OAR
dose distribution for each treatment technique. All dosi-
metric parameters for the whole lung were significantly
higher in the VMAT-only plans than in the two hybrid
plans, while there was no significant difference between
the hybrid plans.
The average heart dose in all cases was 9.7 ± 3.5 Gy.
The irradiation dose to the heart was also highest in the
VMAT-only plan, resulting in Dmean of 13.2 ± 2.3 Gy and
V25Gy of 11.5 ± 6.4%. Like in the whole lung, the primary
and modified hybrid plans showed almost the same
results for the heart dose. Compared to the VMAT-only
plan, the hybrid plans had an approximately 5 Gy lower
mean heart dose. No cases reported the heart volume re-
ceiving ≥40 Gy. Figure 2 shows the typical dose volume
histogram for the whole lung (A) and heart (B). In both
OARs, the VMAT-only plan showed a relatively
high-volume distribution in both low- and high-dose
regions.
For LAD, both the primary hybrid and modified hy-
brid plans showed lower Dmean than VMAT-only plans
(14.7 Gy vs 21.8 Gy, p < 0.001). V10Gy and V20Gy were
also significantly larger in VMAT-only plans. Dmax
showed no significance between the three RT plans.
In every subgroup analysis according to the surgery
and breast shape, the VMAT-only plan showed signifi-
cantly higher dose distribution in terms of mean lung
dose, V20Gy of lung, mean heart dose, and mean LAD
dose (Additional file 3: Table S3).
Three patients in this study had funnel-like chests with
convex lungs whose central lung distances (CLDs, dis-
tance from the chest wall to the edge of the field at the
central axis) were larger than 2.5 cm, resulting in larger
lung volume in the RT field in the conventional tangen-
tial plan (Additional file 4: Figure S3). We evaluated the
lung dose distribution in these patients, and found that
the V5Gy, V10Gy and V20Gy in the VMAT-only plan were
greater than those in the two hybrid plans, as was Dmean
(15.2 Gy, 11.9 Gy, and 12.0 Gy, respectively).
Treatment efficiency
The VMAT-only plans resulted in a longer beam on time
than those of the hybrid plans (115.3 s, 73.5 s, and 77.5 s,
Table 2 The comparison of the organs at risk (OAR) dose using dosimetric parameters
Treatment plans
VMAT only1) Primary hybrid plan2) Modified hybrid plan3) pa
Mean (SD) Mean (SD) Mean (SD) p value 1) vs 2) 1) vs 3) 2) vs 3)
Whole Lung
Dmean (Gy) 14.4 (0.67) 11.8 (1.19) 11.6 (1.18) < 0.001 < 0.001 < 0.001 0.935
V5Gy (%) 67.9 (9.63) 57.0 (6.34) 56.7 (6.38) < 0.001 0.001 0.001 0.993
V10Gy (%) 41.1 (7.9) 33.2 (4.39) 34.0 (5.6) < 0.001 0.003 0.008 0.926
V20Gy (%) 27.5 (2.02) 19.2 (2.42) 19.0 (2.4) < 0.001 < 0.001 < 0.001 0.971
Heart
Dmean (Gy) 13.2 (2.33) 8.0 (2.61) 8.0 (2.6) < 0.001 < 0.001 < 0.001 1
V25Gy (%) 11.5 (6.41) 4.0 (4.71) 4.0 (4.71) 0.001 0.001 0.001 1
V30Gy (%) 6.4 (4.86) 2.4 (3.49) 2.4 (3.49) 0.005 0.024 0.023 1
LAD
Dmean (Gy) 21.8 (3.73) 14.7 (5.25) 14.7 (5.27) < 0.001 0.001 0.001 0.999
Dmax (Gy) 33.7 (2.65) 33.0 (7.19) 32.9 (7.15) 0.566 0.947 0.933 0.999
V10Gy (%) 92.7 (12.88) 56.7 (23.19) 54.9 (23.61) < 0.001 < 0.001 < 0.001 0.97
V20Gy (%) 59.8 (21.3) 29.2 (22.38) 29.0 (22.46) 0.001 0.001 0.001 1
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respectively, p < 0.001) (Table 3). The VMAT-only plans
required 50% more time to deliver the radiation beam
than the modified hybrid plan (115.3 ± 11.6 s vs. 7.5 ±
8.8 s, p < 0.001). All plans had similar MU values with no
statistically significant differences.
Discussion
In this study, the optimal RT plan for SBBC, especially
when including regional LN, was investigated. The PTV
is very large for treating the bilateral breasts and re-
gional LN area. Thus, radiation exposure to OARs, like
the lungs, increases compared to the PTV of unilateral
breast cancer. A modified prescribed dose in a 3D plan
for the right breast, considering the low dose distribu-
tion of the previous VMAT plan for the left breast and
regional LN (i.e., the modified hybrid plan), was the best
way to reduce the OAR dose while delivering the appro-
priate target volume coverage.
VMAT for the left breast and regional LN area im-
proves target volume coverage and reduces treatment
time and radiation dose to the lung, heart, and even
LAD compared to the 3D plan [11, 16, 17]. However,
despite these dosimetric advantages of VMAT, treatment
for SBBC is more complicated. When using the arc in
multiple directions to treat both breasts, a larger volume
of the bilateral lungs is inevitably exposed to irradiation.
To solve this problem, Subramanian et al. proposed the
hybrid–VMAT (h-VMAT) technique [5]. The h-VMAT
planning involves two steps. First, a field-in-field (FIF)
forward planning setup with 80% of the prescription
dose was planned for both breasts. The heart and lungs
were spared using a high definition multi-leaf collimator.
Second, the remaining 20% prescription dose for both
the breasts was optimized using VMAT with three con-
tinuous arcs (arc length: 150°–210°) by keeping the dose
delivered in a FIF arrangement as the base dose plan.
With this method, the radiation dose for the lung was
significantly decreased compared to that in the conven-
tional VMAT plan. However, this strategy could be ap-
plied only for SBBC, but not including regional LN
irradiation, and additional evaluation is needed.
The need to control and minimize the impact of
breathing motion during IMRT for breast cancer has
been investigated by several groups, and the breath-hold
technique or breathing gating technique was identified
as the most convenient and safe approach. As multileaf
collimators without fully-opening jaws are used for
VMAT, several set-up or positional errors could occur.
Efforts are needed to reduce this gap, and Nicolini et al.
suggested optimal VMAT planning for breast cancer
[18]. Alternative images were generated with an artificial
expansion of 10 mm from the body in the breast region
and additional PTV was contoured to this image. The
two treatment plans, which are performed on original
and alternative images respectively, were optimized
using original and alternative images. The proposed
Fig. 2 Comparison of dose volume for the planning target volume of the three radiotherapy plans. Histograms are shown for the (a) whole lung
and (b) heart. The solid line represents the VMAT-only plan, the dotted line represents the primary hybrid plan, and the dashed line represents
the modified hybrid plan (the two hybrid plans show almost the same dose distribution to the whole lung and heart)
Table 3 The comparison of the delivery parameters for VMAT only, primary hybrid, and modified hybrid plan
VMAT only Primary hybrid plan Modified hybrid plan p
valueMean (SD) Mean (SD) Mean (SD)
Beam on time (s) 115.3 (11.6) 73.5 (8.8) 77.5 (8.8) < 0.001
MU segment 795.1 (131) 827.5 (59.2) 811.7 (67.3) 0.424
Abbreviations: MU monitor unit
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planning strategy could represent a robust approach that
could account for moderate changes in target or body
volume during the course of breast radiotherapy and
also account for residual intrafractional respiratory mo-
tion in VMAT.
Here, we conducted a comparative study for the opti-
mal RT plan for SBBC including regional LN irradiation.
Among the previous studies on SBBC, Seppälä et al. and
Boman et al. reported RT for SBBC including RNI [19,
20]. However, they only included axillary LNs and/or in-
ternal mammary LNs, whereas we included supraclavi-
cular LNs; this resulted in a significant increase in lung
dose. We implemented a hybrid plan using both VMAT
and 3D-CRT instead of VMAT for this large target vol-
ume. Specifically, we used a 3D-tangential plan consider-
ing the widespread but low-dose area generated by
previous VMAT plans on the left side. The dose cover-
age for the PTV was comparable to that of the
VMAT-only plan, and the dose to OAR was significantly
reduced. Especially for the lung, VMAT plans generally
produced a larger volume in which a low dose of radi-
ation is distributed, compared to that of a tangential
field [11]. Considering the mean lung dose (MLD) of 6–
16 Gy in previous SBBC studies [4, 9, 19, 21], our results
were comparable to previous reports, despite the inclu-
sion of the regional LN area such as the internal mam-
mary chain and supraclavicular area.
In breast cancer, evidence is accumulating that RT can
increase the risk of heart disease [22], and an increased
risk of stenosis in the LAD for left-sided RT compared
to right-sided RT has been reported [23]. Contemporary
techniques usually deliver lower mean doses to the heart
than they did in the past, but some parts of the heart
may still receive high doses including the LAD, which is
located near the left breast and may receive a high dose
in RT for left breast cancer. Although Darby et al. sug-
gested that increasing the mean heart dose could in-
crease the incidence of ischemic heart disease [22, 24],
specific thresholds have been defined for neither the
dose in the heart nor the dose in the LAD, according to
several authors [25]. Since no threshold doses for the
heart and LAD are available and the clinical effect of
low doses is not completely clear, we think the best clin-
ical practice would be to keep the dose in the heart and
LAD as low as achievable. In this study, the mean dose
and VxGy of the heart and LAD were also highest in the
bilateral VMAT plan. Hybrid techniques using VMAT
+3D-CRT can reduce the heart dose, and additional
methods such as deep inspiration breath holding can re-
duce the radiation exposure to cardiac structures.
Although the hybrid plans showed shorter beam on
time than that of the VMAT-only plan, hybrid plans
would consume more treatment time due to the move-
ment of the isocenter. Moreover, the setup during
treatment could result in some errors involving factors
such as quality of treatment and patients’ satisfaction.
However, previous studies reported the feasibility of the
two-isocenter technique in treating SBBC [20]. The
two-isocenter technique induced 2–5 mm of errors but
no clinically significant change of dose coverage. The
studies also emphasized that the two-isocenter VMAT
technique could reduce the mean dose for the lung and
heart better than the single isocenter technique.
There are several limitations in this study. First, we
only considered the regional LN in the left side. For bi-
lateral regional LN, the VMAT-plan may be the best, as
the AP field for supraclavicular LN in 3D CRT generates
a large amount of upper lung dose. To counter this issue
further evaluation is needed based on the two-isocenter
VMAT suggested by Boman et al. [18]. Second, this
study was conducted using an Asian population, and the
criterion for classifying large breasts was extremely small
when compared to those for Caucasian populations;
therefore, further studies based on Caucasian popula-
tions are needed. In addition, only the beam delivery
time was calculated, and it was the longest when the
VMAT-only plan was performed. In actual patient treat-
ment, however, two isocenters are used in the hybrid
plan, which may lead to a longer patient set-up time.
Therefore, further evaluation is needed to confirm
whether hybrid plans are more efficient than the
VMAT-only plan in clinical use. Moreover, since VMAT
plans can be adjusted according to the physician’s
intention, better plans could be generated by modifying
the geometry of the beams.
Conclusions
The modified hybrid plan using VMAT + modified
3D-CRT is best when considering both PTV coverage
and protection of OARs. To identify the clinical efficacy
of the modified hybrid plan in terms of oncologic out-
comes and treatment toxicities, advanced long-term
follow-up studies with a large number of patients are
needed. In addition, there is no standard guideline for
the RT of SBBC including RNI, so it is also necessary to
determine whether there are additional RT strategies be-
yond the method presented in this study.
To reach a compromise between dosimetric and thera-
peutic efficiency, and to improve the treatment of pa-
tients with SBBC, further studies of the optimal RT
planning method, with a larger number of participants,
should be performed.
Additional files
Additional file 1: Figure S1. A large breast was defined as the one
where the deputh was > 3 cm in an axial computed tomography (CT)
image (A), whereas a small breast was defined as one where the depth
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from the nipple to the chest wall was < 3 cm (B). (C) is the CT image of
patient who received left total mastectomy. (TIF 341 kb)
Additional file 2: Figure S2. Isodose distribution of VMAT plan of left
PTV. Out-field dose distribution of the left VMAT plan is observed in right
breast. (TIF 495 kb)
Additional file 3: Table S1. Patients and tumor characteristics. Table
S2. The comparison of planning target volume (PTV) coverage for VMAT
only, primary hybrid, and modified hybrid plans according to the
patients’ morphologic variations using dosimetric parameters. Table S3.
The comparison of the organs at risk dose according to the patients’
morphologic variations using dosimetric parameters (DOCX 28 kb)
Additional file 4: Figure S3. A computed tomography image of a
patients whose central lung distance (CLDs, distance from the chest wall to
the edge of the field at the central axis) is larger than 2.5 cm. (TIF 318 kb)
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